Morsani College of Medicine
Department of Molecular Medicine
Joint and Affiliate Faculty
Post-Doctorates / Research Associates
How To Apply
Master's of Science Program
Allergy, Immunology and Infectious Diseases
USF Health Byrd Alzheimer's Institute
Children's Research Institute (CRI)
Center for Drug Discovery and Innovation
H. Lee Moffitt Cancer Center
James A Haley Veteran's Hospital
Bay Pines VA Healthcare System
Assistant Professor, COLLEGE OF MEDICINE MOLECULAR MEDICINE
I am an active member of the Immunology Program at the Moffitt Cancer Center. I received my post-doctoral training in Transplant Immunology from Moffitt. Currently, my research focuses on Tumor Immunology/Pancreatic Cancer. Pancreatic cancer is one the top five cancers in the U.S. and is considered the most aggressive of all human cancers. Current cancer therapies are ineffective due to the expansion of regulatory immune cells such as MDSC and Tregs in pancreatic cancer patients. More specifically my research focuses on how immune regulatory cells respond to pancreatic cancer using pre-clinical pancreatic cancer animal models from USF and Moffitt in addition to clinical samples from pancreatic cancer patients from Moffitt. The overall goal of my research is to develop novel therapeutic strategies that may be translated and effective for the eradication of pancreatic cancer in humans.
View Our Full Calendar
Graduate Research Assistant, COLLEGE OF MEDICINE MOLECULAR MEDICINE
- Our lab focuses on the interactions of molecular chaperones with various proteins associated with neurodegenerative disorders. The main focus of the lab is exploring the relationship between the protein Tau and Alzheimer’s Disease, but we have also recently started to explore the relationship between Myocilin and the disease Glaucoma.
-My project focuses on understanding the relationship between Myocilin and the co-chaperone Grp-94 in the disease Glaucoma. Using novel Grp94 inhibitors, I will look at inhibiting Grp94’s interaction with myocilin leading to clearance from the eye, and a reduction of symptoms associated with Glaucoma.